Literature DB >> 17121855

Suppression of calpain-dependent cleavage of the CDK5 activator p35 to p25 by site-specific phosphorylation.

Hirotsugu Kamei1, Taro Saito, Mirai Ozawa, Yuichi Fujita, Akiko Asada, James A Bibb, Takaomi C Saido, Hiroyuki Sorimachi, Shin-Ichi Hisanaga.   

Abstract

Cdk5 is a proline-directed Ser/Thr protein kinase predominantly expressed in postmitotic neurons together with its activator, p35. N-terminal truncation of p35 to p25 by calpain results in deregulation of Cdk5 and contributes to neuronal cell death associated with several neurodegenerative diseases. Previously we reported that p35 occurred as a phosphoprotein, phospho-p35 levels changed with neuronal maturation, and that phosphorylation of p35 affected its vulnerability to calpain cleavage. Here, we identify the p35 residues Ser(8) and Thr(138) as the major sites of phosphorylation by Cdk5. Mutagenesis of these sites to unphosphorylatable Ala increased susceptibility to calpain in cultured cells and neurons while changing them to phosphomimetic glutamate-attenuated cleavage. Furthermore, phosphorylation state-specific antibodies to these sites revealed that Thr(138) was dephosphorylated in adult rat, although both Ser(8) and Thr(138) were phosphorylated in prenatal brains. In cultured neurons, inhibition of protein phosphatases converted phosho-Ser(8) p35 to dual phospho-Ser(8)/Thr(138) p35 and conferred resistance to calpain cleavage. These results suggest phosphorylation of Thr(138) predominantly defines the susceptibility of p35 to calpain-dependent cleavage and that dephosphorylation of this site is a critical determinant of Cdk5-p25-induced cell death associated with neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121855     DOI: 10.1074/jbc.M610541200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

2.  Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  Mol Cell Proteomics       Date:  2010-01-23       Impact factor: 5.911

3.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

Review 4.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

5.  Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.

Authors:  Aurélie de Thonel; Saima E Ferraris; Hanna-Mari Pallari; Susumu Y Imanishi; Vitaly Kochin; Tomohisa Hosokawa; Shin-ichi Hisanaga; Cecilia Sahlgren; John E Eriksson
Journal:  Mol Biol Cell       Date:  2010-03-03       Impact factor: 4.138

6.  Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.

Authors:  Yan Yang; Haibo Wang; Jie Zhang; Fucheng Luo; Karl Herrup; James A Bibb; Richard Lu; Robert H Miller
Journal:  Dev Biol       Date:  2013-04-10       Impact factor: 3.582

7.  PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation.

Authors:  Jens Thorsten Stieler; Torsten Bullmann; Franziska Kohl; Brian M Barnes; Thomas Arendt
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

8.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

Review 9.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

10.  Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology.

Authors:  Douglas A Meyer; Edmond Richer; Stanley A Benkovic; Kanehiro Hayashi; Janice W Kansy; Carly F Hale; Lily Y Moy; Yong Kim; James P O'Callaghan; Li-Huei Tsai; Paul Greengard; Angus C Nairn; Christopher W Cowan; Diane B Miller; Pietro Antich; James A Bibb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.